Robert J. Plunkett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Robert J. Plunkett has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Andrew J. Fabiano
Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA
1 shared publicationCarolyn Doyle
Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA
1 shared publication- Dheerendra Prasad
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo
1 shared publication Frederick Sachs
A Physiology and Biophysics, 301 Cary Hall, SUNY at Buffalo, Buffalo, NY 14214, United States
1 shared publicationJustin W. Gorski
Department of Neurosurgery, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA
1 shared publication- Kenneth V. Snyder
Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA
1 shared publication
Latest Publications
- Open Access
- 27 August 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 141, 111587
Hypofractionated vs. single-session Gamma Knife radiosurgery for orbital cavernous hemangiomas: A systematic review, meta-analysis, and institutional case series
- 27 August 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 141, 111587
Open AccessHypofractionated vs. single-session Gamma Knife radiosurgery for orbital cavernous hemangiomas: A systematic review, meta-analysis, and institutional case series
- Open Access
- 1 August 2012
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 13 (8) , 1088-1090
Intrathecal Medications in Post-Herpetic Neuralgia: Table 1
- 1 August 2012
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 13 (8) , 1088-1090
Open AccessIntrathecal Medications in Post-Herpetic Neuralgia: Table 1
- 1 December 2010
- Vol. 30 (12) , 4851-60
Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains.
To study the neuropathology and selected tumour markers of malignant gliomas, an animal glioma model was developed using the implantation of U87 human glioblastoma cells into chick chorioallantoic membrane. The immunohistochemical characteristics were studied and compared with an orthotopic rodent model. The U87 cell suspension was inoculated onto the chick chorioallantoic membrane on embryonic day seven and into the brain of nude rats. Brain tumour sections were examined for various known tumour markers by routine haematoxylin and eosin staining and immunohistochemical analyses. The immunohistochemical analyses showed that S100 protein, glial fibrillary acidic protein and synaptophysin expressions, initially present in tissue culture, were lost in both models. Persistent kallikrein, CD68 and vimentin expressions in U87 cells, as well as in both animal tumour models, were detected. The percentage of p53-positive nuclei, which was higher in the tumours grown on the chick chorioallantoic membrane than in rats, did not correlate with the Ki-67 labelling index. Strong cathepsin expression was maintained from the cell culture to both tumour models. CD3-positive cells and numerous leukocytes, but no CD20-positive cells were detected in any of the animal samples, indicating the immunological response of the host to be primarily cellular. Stronger immune reaction for vascular endothelial growth factor in rats correlated with an observed increase in vascular proliferation in these tumours. A simple, fast-growing, cheap and well-defined chick chorioallantoic membrane model of glioma was established, providing a basis for further experimental studies of genetic and protein expression during human glioma tumourigenesis. This model may possibly replace some rodent models for selective studies.
- 1 December 2010
- Vol. 30 (12) , 4851-60
Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains.
To study the neuropathology and selected tumour markers of malignant gliomas, an animal glioma model was developed using the implantation of U87 human glioblastoma cells into chick chorioallantoic membrane. The immunohistochemical characteristics were studied and compared with an orthotopic rodent model. The U87 cell suspension was inoculated onto the chick chorioallantoic membrane on embryonic day seven and into the brain of nude rats. Brain tumour sections were examined for various known tumour markers by routine haematoxylin and eosin staining and immunohistochemical analyses. The immunohistochemical analyses showed that S100 protein, glial fibrillary acidic protein and synaptophysin expressions, initially present in tissue culture, were lost in both models. Persistent kallikrein, CD68 and vimentin expressions in U87 cells, as well as in both animal tumour models, were detected. The percentage of p53-positive nuclei, which was higher in the tumours grown on the chick chorioallantoic membrane than in rats, did not correlate with the Ki-67 labelling index. Strong cathepsin expression was maintained from the cell culture to both tumour models. CD3-positive cells and numerous leukocytes, but no CD20-positive cells were detected in any of the animal samples, indicating the immunological response of the host to be primarily cellular. Stronger immune reaction for vascular endothelial growth factor in rats correlated with an observed increase in vascular proliferation in these tumours. A simple, fast-growing, cheap and well-defined chick chorioallantoic membrane model of glioma was established, providing a basis for further experimental studies of genetic and protein expression during human glioma tumourigenesis. This model may possibly replace some rodent models for selective studies.
- 1 September 2010
- Published by Elsevier in Neuroscience Letters
- Vol. 481 (2) , 115-119
Neurite outgrowth from PC12 cells is enhanced by an inhibitor of mechanical channels
- 1 September 2010
- Published by Elsevier in Neuroscience Letters
- Vol. 481 (2) , 115-119
Neurite outgrowth from PC12 cells is enhanced by an inhibitor of mechanical channels
- 1 October 2009
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 95 (1) , 37-48
Estrogen increases survival in an orthotopic model of glioblastoma
Despite the male preponderance for developing glial tumors and a body of published literature that suggests a female gender advantage for long term survival in both human and animal studies, there have been relatively few rigorous investigations into the hormonal effects on glial tumor growth. In a previous study, we concluded that estrogen played a major role in the female survival bias seen in an intracerebral nude rat model of glioblastoma multiforme. Here we explore the potential therapeutic effect of exogenous estradiol delivery in nude rats with orthotopic glioblastoma tumors and examine the mechanism of action of estradiol on reducing tumor growth in this animal model. We administered estradiol, in several dosing regimens, to male, female and ovariectomized nude rats in a survival study. Brain sections, taken at various time points in tumor progression, were analyzed for estrogen receptor protein, proliferative index and apoptotic index. Estradiol increased survival of male, female and ovariectomized nude rats with intracerebral U87MG tumors, in a gender specific manner. The estradiol mediated effect occurred early in tumor progression, and appeared to be caused in-part by an increase in apoptotic activity. It remains unclear if estradiol’s effect is direct or indirect and if it is estrogen receptor mediated. Estradiol-based or adjunctive therapy may be beneficial in treating GBM and further study is clearly warranted.
- 1 October 2009
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 95 (1) , 37-48
Estrogen increases survival in an orthotopic model of glioblastoma
Despite the male preponderance for developing glial tumors and a body of published literature that suggests a female gender advantage for long term survival in both human and animal studies, there have been relatively few rigorous investigations into the hormonal effects on glial tumor growth. In a previous study, we concluded that estrogen played a major role in the female survival bias seen in an intracerebral nude rat model of glioblastoma multiforme. Here we explore the potential therapeutic effect of exogenous estradiol delivery in nude rats with orthotopic glioblastoma tumors and examine the mechanism of action of estradiol on reducing tumor growth in this animal model. We administered estradiol, in several dosing regimens, to male, female and ovariectomized nude rats in a survival study. Brain sections, taken at various time points in tumor progression, were analyzed for estrogen receptor protein, proliferative index and apoptotic index. Estradiol increased survival of male, female and ovariectomized nude rats with intracerebral U87MG tumors, in a gender specific manner. The estradiol mediated effect occurred early in tumor progression, and appeared to be caused in-part by an increase in apoptotic activity. It remains unclear if estradiol’s effect is direct or indirect and if it is estrogen receptor mediated. Estradiol-based or adjunctive therapy may be beneficial in treating GBM and further study is clearly warranted.